0001209191-23-004876.txt : 20230125 0001209191-23-004876.hdr.sgml : 20230125 20230125175509 ACCESSION NUMBER: 0001209191-23-004876 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230123 FILED AS OF DATE: 20230125 DATE AS OF CHANGE: 20230125 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nuyten Dimitry SA CENTRAL INDEX KEY: 0001776564 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38419 FILM NUMBER: 23553397 MAIL ADDRESS: STREET 1: 740 HEINZ AVENUE STREET 2: C/O ADURO BIOTECH, INC. CITY: BERKELEY STATE: CA ZIP: 94710 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arcus Biosciences, Inc. CENTRAL INDEX KEY: 0001724521 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473898435 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 BUSINESS PHONE: (510) 694-6200 MAIL ADDRESS: STREET 1: 3928 POINT EDEN WAY CITY: HAYWARD STATE: CA ZIP: 94545 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2023-01-23 0 0001724521 Arcus Biosciences, Inc. RCUS 0001776564 Nuyten Dimitry SA 3928 POINT EDEN WAY HAYWARD CA 94545 0 1 0 0 Chief Medical Officer Common Stock 2023-01-23 4 A 0 34000 0.00 A 76500 D Stock Option (Right to Buy) 22.02 2023-01-23 4 A 0 138200 0.00 A 2033-01-22 Common Stock 138200 138200 D Represents the grant of restricted stock units that vest in four equal annual installments beginning December 15, 2023, subject to the Reporting Person's continued service to the Company. The option becomes exercisable in 48 equal monthly installments after January 1, 2023, subject to the Reporting Person's continued service to the Company. /s/ Carolyn Tang, Attorney-in-Fact 2023-01-25